Dangyang launches high-end medical silicone base with billion-yuan investment
2025-08-14 19:08:45
By Liu Xinyu
Dangyang has begun building a high-end medical silicone materials base, expected to generate an average annual sales revenue of 1.22 billion yuan once operating at full capacity.
Dangyang has begun building a high-end medical silicone materials base, expected to generate an average annual sales revenue of 1.22 billion yuan once operating at full capacity.
Photo by Chen Yangzhi
The Xinshiyuan New Materials Project, backed by the Dangyang State-owned Capital Investment Group, is under construction at Baling Chemical Park in Yuxi Town and is moving forward rapidly.
The project is expected to be fully operational by the first half of 2026. When complete, it will produce 2,500 tons of medical lubricating silicone oil, 3,000 tons of premium high-temperature release agents, and 45 billion self-lubricating medical rubber stoppers (non-butyl). This will result in an average annual sales revenue of 1.22 billion yuan and an estimated annual tax contribution of 55 million yuan.
With a total investment of 1 billion yuan, this provincial key project aims to establish an advanced organic silicone industrial base in China. Covering 5.8 acres, Phase I will focus on constructing production facilities for premium high-temperature release agents and medical self-lubricating silicone oil, as well as warehouses and an office building. Phase II will add production lines for self-lubricating medical rubber stoppers.
As part of Hubei Province’s new materials development strategy, the project’s core products are supported by national policies and align with the national and provincial 14th Five-Year Plans as well as the 2035 Vision Outline. Once completed, it will strengthen the regional new materials industry and bolster the supply chain for high-end medical consumables.
Zhang Kai contributed to this story.
